Explore 3 Stock Ideas & Industry Insights Download Free Report

Cyclo3pss Corporation

Healthcare US CYPS

0.0001USD
0.00(0%)

Last update at 2026-06-18T13:30:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

-0.0001
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.00405M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.87500M
  • Revenue TTM0.37M
  • Revenue Per Share TTM0.01
  • Gross Profit TTM 0.13M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2002-02-28 2001-02-28 2000-02-29 1999-02-28
Type yearly yearly yearly yearly
Date 2002-02-28 2001-02-28 2000-02-29 1999-02-28
Income before tax - - - -
Minority interest - - - -
Net income - - - -
Selling general administrative - - - -
Selling and marketing expenses - - - -
Gross profit - - - -
Reconciled depreciation - - - -
Ebit -0.95678M -1.06629M -0.94271M -2.33283M
Ebitda - - - -
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income - - - -
Other operating expenses - - - -
Interest expense 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - -
Interest income - - - -
Net interest income - - - -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense - - - -
Total revenue - - - -
Total operating expenses - - - -
Cost of revenue - - - -
Total other income expense net - - - -
Discontinued operations 0.23M 0.04M 0.04M 0.04M
Net income from continuing ops - - - -
Net income applicable to common shares -0.85023M -1.13285M -2.19476M -3.23286M
Preferred stock and other adjustments - - - -
Breakdown 2002-02-28 2001-02-28 2000-02-29 1999-02-28
Type yearly yearly yearly yearly
Date 2002-02-28 2001-02-28 2000-02-29 1999-02-28
Total assets - - - -
Intangible assets - - - -
Earning assets - - - -
Other current assets - - - -
Total liab - - - -
Total stockholder equity - - - -
Deferred long term liab - - - -
Other current liab 0.10M 0.10M 0.10M -
Common stock 0.04M 0.03M 0.03M 0.02M
Capital stock - - - -
Retained earnings -21.11072M -20.26050M -19.14564M -17.18523M
Other liab - - - -
Good will - - - -
Other assets - 0.02M - 0.00522M
Cash - - - -
Cash and equivalents - - - -
Total current liabilities 1.13M 1.35M 1.06M 0.40M
Current deferred revenue - - - -
Net debt - - - -
Short term debt - - - -
Short long term debt - - - -
Short long term debt total - - - -
Other stockholder equity - 0.19M - -
Property plant equipment 0.01M 0.05M 0.14M 0.23M
Total current assets 0.15M 0.17M 0.20M 0.19M
Long term investments - - - -
Net tangible assets -0.96697M -1.11252M -0.72298M 0.03M
Short term investments - - - -
Net receivables 0.07M 0.11M 0.07M 0.05M
Long term debt - - - -
Inventory - - 0.02M 0.07M
Accounts payable 0.13M 0.12M 0.26M 0.24M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other - - - -
Deferred long term asset charges - - - -
Non current assets total - - - -
Capital lease obligations - - - -
Long term debt total - - - -
Breakdown 2002-02-28 2001-02-28 2000-02-29 1999-02-28
Type yearly yearly yearly yearly
Date 2002-02-28 2001-02-28 2000-02-29 1999-02-28
Investments - - - -
Change to liabilities 0.04M -0.36471M 0.42M -0.40144M
Total cashflows from investing activities 0.11M -0.09867M -0.03436M -0.12602M
Net borrowings 0.29M 0.76M 0.24M -0.02466M
Total cash from financing activities 0.52M 1.15M 0.48M 1.69M
Change to operating activities -0.00586M 0.00235M 0.04M 0.03M
Net income -0.85023M -1.11485M -1.96041M -2.77705M
Change in cash 0.01M -0.04554M 0.07M -0.53714M
Begin period cash flow - - - -
End period cash flow - - - -
Total cash from operating activities -0.61804M -1.09757M -0.37192M -2.10508M
Issuance of capital stock - - - -
Depreciation 0.08M 0.14M 0.15M 0.33M
Other cashflows from investing activities -0.12039M -0.08000M -0.08000M -0.08000M
Dividends paid - - - -
Change to inventory - - 0.05M 0.09M
Change to account receivables -0.05110M 0.04M -0.02314M 0.07M
Sale purchase of stock - - - -
Other cashflows from financing activities - - - -
Change to netincome 0.16M 0.20M 0.95M 0.56M
Capital expenditures 0.00000M 0.00555M 0.00495M 0.11M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital - - - -
Stock based compensation - - - -
Other non cash items - - - -
Free cash flow - - - -

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
CYPS
Cyclo3pss Corporation
- -% 0.0001 - - 0.01 -
TMO
Thermo Fisher Scientific Inc
-0.6 0.13% 464.01 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation
1.02 0.58% 178.19 29.09 28.01 5.67 3.20 6.00 19.09
A
Agilent Technologies Inc
-0.57 0.45% 126.49 34.36 26.39 6.59 7.14 6.78 23.56
IDXX
IDEXX Laboratories Inc
-16.36 2.91% 545.73 49.99 45.66 11.29 27.85 11.46 34.46

Reports Covered

Stock Research & News

Profile

Cyclo3pss Corporation engages in the licensing, manufacture, sale, and installation of ozone food processing products; and ozone washing and laundry sorting and counting systems for commercial and institutional laundries. It also engages in the research and development of technologies for the sterilization and/or disinfection of certain consumer products. The company was founded in 1927 and is based in Salt Lake City, Utah. In July 2002, the Board of Directors of Cyclo3pss determined to suspend all operations of the company immediately due to an inability to locate willing investors and to secure necessary and suitable financing.

Cyclo3pss Corporation

7105 South Highland Drive, Salt Lake City, UT, United States, 84121

  • 801-972-9090
  • Employees : 4

Key Executives

Name Title Year Born
Mr. William R. Stoddard Chief Exec. Officer and Director 1952
Ms. Mondis Nkoy Principal Financial Officer, Controller and Corp. Sec. 1964
Mr. William R. Stoddard Chief Executive Officer and Director 1952
Ms. Mondis Nkoy Principal Financial Officer, Controller and Corporate Secretary 1964

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions